Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 430.17M P/E - EPS this Y -94.40% Ern Qtrly Grth -
Income -73.48M Forward P/E -3.61 EPS next Y 4.80% 50D Avg Chg 9.00%
Sales 110.5M PEG - EPS past 5Y - 200D Avg Chg -
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -39.00%
Recommedations 2.00 Quick Ratio 0.90 Shares Outstanding 152.09M 52W Low Chg 86.00%
Insider Own 13.93% ROA -23.84% Shares Float 65.77M Beta -1.13
Inst Own 64.71% ROE - Shares Shorted/Prior 3.53M/3.35M Price 4.37
Gross Margin -26.30% Profit Margin -66.50% Avg. Volume 441,150 Target Price 14.89
Oper. Margin -177.72% Earnings Date Nov 7 Volume 287,782 Change 0.00%
About Wave Life Sciences Ltd.

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

Wave Life Sciences Ltd. News
11/15/24 Wave Life Sciences to Present at Jefferies London Healthcare Conference
11/15/24 Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20
11/14/24 Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations
11/13/24 WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
11/12/24 Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates
11/12/24 Wave Life Sciences: Q3 Earnings Snapshot
11/12/24 Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
11/05/24 Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy?
11/04/24 Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
11/03/24 Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them.
10/30/24 Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
10/29/24 How to play biotech stocks: Insmed and Wave Life Sciences
10/28/24 Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know
10/24/24 1 Brand-New Big Reason to Buy This Biotech Stock Right Now
10/23/24 What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now?
03:15 PM Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
10/17/24 Wave Life Sciences Shares Surge After RNA Editing Discovery
10/17/24 WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data
10/17/24 Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last?
10/16/24 Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed.
WVE Chatroom

User Image Pfreakstocks Posted - 6 days ago

$KRRO $PRQR $WVE @valueforme do you or ANYONE know why KRRO is down 50$ basically from its recent high? What happenedđź« 

User Image bioanticipation Posted - 6 days ago

$WVE wow what a call

User Image tttggg Posted - 1 week ago

@Oknrv I think you misinterpreted her point. She tried to make a case for $ARWR $WVE, not $SRRK.

User Image Quantumup Posted - 1 week ago

Truist⬆️PT $WVE $36 was $17/Buy, says recent +VE🔬w/ a differentiated/impressive efficacy profiles in HD, DMD /AATD, give them > conviction that $WWE has the winning ASO/RNAI/RNA editing platform—⬆️PT on improved outlook for pipeline programs/tech value of the platform: $krro $prqr $ntla

User Image Stocks4thought Posted - 1 week ago

$WVE What happened?

User Image OpenOutcrier Posted - 1 week ago

$WVE (-9.1% pre) Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update https://ooc.bz/l/47804

User Image Trader2004 Posted - 1 week ago

@Jabed206 Lol you couldn't be more wrong $NGNE reports data next week...If it's good to great news $TSHA pops...Just like $KRRO on $WVE news....You really think that crazy volume 11/4-11/8 was about nothing?

User Image TraderIsaac Posted - 1 week ago

$WVE Inside and up.

User Image optionsSucks Posted - 1 week ago

$WVE $20+ on Monday??

User Image TraderIsaac Posted - 1 week ago

$WVE On WL, inside day.

User Image Thestocktraderhubzee Posted - 2 weeks ago

WATCHLIST NOV 05 2024 $CMTL Comtech Telecommunications shares are trading lower after B. Riley Securities cut its price target on the stock from $12.25 to $9.25. $WVE B. Riley Securities Maintains Buy on WAVE Life Sciences, Raises Price Target to $22 $CELH B. Riley Securities Maintains Buy on Celsius Holdings, Lowers Price Target to $47 $EL B. Riley Securities Maintains Neutral on Estee Lauder Cos, Lowers Price Target to $70 $MA Morgan Stanley Maintains Overweight on Mastercard, Raises Price Target to $544

User Image Stocks4thought Posted - 2 weeks ago

$PRQR People need to realize this is a clone of $WVE program in ADAR- resp for the stock almost doubling $LLY partner loves me.

User Image Stocks4thought Posted - 10/29/24

$RPTX $WVE maybe $GSK waves to this one too- https://www.gsk.com/en-gb/behind-the-science-magazine/synthetic-lethality-accelerating-precision-cancer-treatments/

User Image NoLimitKhalil Posted - 10/29/24

$WVE still waiting for that Pop

User Image skeezbag Posted - 10/28/24

$ARWR $300m separates this pipeline from a company with a phase two drug $WVE 🤡💩 There's obviously a reason why

User Image Stocks4thought Posted - 10/25/24

$PRME Just like $WVE with $GSK wait for it https://finance.yahoo.com/news/prime-medicine-inks-cell-therapy-123845824.html

User Image Stocks4thought Posted - 10/23/24

$PRQR Remember why this is down- the offering vs the platform. ADAR---------------which $WVE validated last week or earlier..............relax enjoy your popcorn and watch the movie.

User Image Stocks4thought Posted - 10/23/24

$PRQR EXTREMELY POSITIVE- its common practice to short a stock b4 and offering- everyone on this board spoke of the when is it coming. They didn't discount the price- so that tells you something (it was done organically- orchestrated- yes- its a crime game = that Wall Street). undervalued relative to the platform--------easily double digit stock- given $WVE POC for Adar.

User Image traderHB Posted - 10/23/24

$WVE will probably slowly fill the gap below before it can really take off. Bearish for now. No position (yet,lol).

User Image TraderIsaac Posted - 10/22/24

$WVE another one for RMV 0 WL, with HVC.

User Image Cirrus861 Posted - 10/22/24

$WVE tight consolidation with lower volume after a big move. #swingtrading #sp500 #stocks

User Image Sergiy79 Posted - 10/22/24

$WVE I bought in February at 3.6 and sold at around 8 too early ((. Reinvested to $SGMT at 3.56 and waiting )

User Image Sergiy79 Posted - 10/22/24

$WVE Blackrock can afford to lose or wait for years )

User Image ezimon Posted - 10/22/24

$WVE Are you holding any short positions in this stock?

User Image Wizardoz Posted - 10/22/24

$WVE blackrock took 5% stake as per sec filing Oct 18. Guess it’s from the last capital raise of 230mln, along with gsk and ra capital.

User Image Longroader Posted - 4 weeks ago

@johnnygogogo De Boer had a wry smirk at latest interview when asked about $WVE $PRQR owns ADAR space. Let it grow and mature. Collect dues later.

User Image Longroader Posted - 4 weeks ago

$PRQR Just to catch up with $WVE is 10x. Money will pour in. AATD is not our thing here. Patience.

User Image Wed21 Posted - 4 weeks ago

$WVE another 50,000 dilution. Price not moving as usual…

User Image Wed21 Posted - 1 month ago

$WVE insiders selling more on this spike. Let’s all wait for the filed forms after

User Image Wed21 Posted - 1 month ago

$WVE boring stock. Dump 10%

Analyst Ratings
Jones Trading Buy Sep 25, 24
HC Wainwright & Co. Buy Sep 25, 24
B. Riley Securities Buy Sep 19, 24
JP Morgan Overweight Sep 9, 24
Jones Trading Buy Aug 9, 24
HC Wainwright & Co. Buy Jun 26, 24
Mizuho Outperform Jun 25, 24
Wells Fargo Overweight May 15, 24
Truist Securities Buy Apr 1, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
RA CAPITAL MANAGEMENT, L.P. Director Director Dec 11 Buy 5.00 1,000,000 5,000,000 18,202,009 01/17/24
Moran Kyle Chief Financial Offi.. Chief Financial Officer Aug 23 Sell 4.752 37,062 176,119 46,120 08/23/23
Vargeese Chandra See Remarks See Remarks Feb 16 Sell 4.03 10,249 41,303 106,624 02/17/23
BOLNO PAUL President and CEO President and CEO Feb 16 Sell 4.04 29,400 118,776 407,425 02/17/23
Francis Chris See Remarks See Remarks Feb 16 Sell 4.03 10,258 41,340 79,714 02/17/23
Moran Kyle Chief Financial Offi.. Chief Financial Officer Feb 16 Sell 4.04 9,729 39,305 79,751 02/17/23
Vargeese Chandra See Remarks See Remarks May 04 Sell 1.72 16,714 28,748 111,095 05/06/22
BOLNO PAUL President and CEO President and CEO May 04 Sell 1.72 33,501 57,622 436,825 05/06/22
Moran Kyle Chief Financial Offi.. Chief Financial Officer May 04 Sell 1.72 5,021 8,636 84,567 05/06/22
Panzara Michael A. See Remarks See Remarks May 04 Sell 1.72 16,714 28,748 109,103 05/06/22
Francis Chris See Remarks See Remarks May 04 Sell 1.72 10,867 18,691 89,972 05/06/22
Moran Kyle Chief Financial Offi.. Chief Financial Officer Feb 16 Sell 2.31 9,204 21,261 74,588 02/18/22
Francis Chris See Remarks See Remarks Feb 16 Sell 2.31 10,123 23,384 68,339 02/18/22
Vargeese Chandra Chief Technology Off.. Chief Technology Officer Feb 16 Sell 2.32 10,603 24,599 77,809 02/18/22
BOLNO PAUL President and CEO President and CEO Feb 16 Sell 2.32 33,150 76,908 377,826 02/18/22
Panzara Michael A. See Remarks See Remarks Feb 16 Sell 2.31 10,603 24,493 75,817 02/18/22
BOLNO PAUL President and CEO President and CEO Feb 18 Sell 10.57 11,205 118,437 410,976 02/18/21
Panzara Michael A. See Remarks See Remarks Feb 18 Sell 10.57 2,929 30,960 86,420 02/18/21
BOLNO PAUL President and CEO President and CEO Sep 17 Option 2.48 100,000 248,000 372,181 09/17/20
BOLNO PAUL President and CEO President and CEO Sep 17 Sell 15 100,000 1,500,000 272,181 09/17/20